Drugging evolution of antibiotic resistance at a regulatory network hub

Author:

Zhai Yin1ORCID,Pribis John P.23ORCID,Dooling Sean W.24ORCID,Garcia-Villada Libertad25ORCID,Minnick P.J.125ORCID,Xia Jun25,Liu Jingjing25,Mei Qian56,Fitzgerald Devon M.25ORCID,Herman Christophe2357ORCID,Hastings P.J.25ORCID,Costa-Mattioli Mauro24ORCID,Rosenberg Susan M.12356ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

3. Graduate Program in Integrative Molecular and Biomedical Sciences, Baylor College of Medicine, Houston, TX 77030, USA.

4. Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.

5. The Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

6. Systems, Synthetic, and Physical Biology Program, Rice University, Houston, TX 77030, USA.

7. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.

Abstract

Evolution of antibiotic resistance is a world health crisis, fueled by new mutations. Drugs to slow mutagenesis could, as cotherapies, prolong the shelf-life of antibiotics, yet evolution-slowing drugs and drug targets have been underexplored and ineffective. Here, we used a network-based strategy to identify drugs that block hubs of fluoroquinolone antibiotic-induced mutagenesis. We identify a U.S. Food and Drug Administration– and European Medicines Agency–approved drug, dequalinium chloride (DEQ), that inhibits activation of the Escherichia coli general stress response, which promotes ciprofloxacin-induced (stress-induced) mutagenic DNA break repair. We uncover the step in the pathway inhibited: activation of the upstream “stringent” starvation stress response, and find that DEQ slows evolution without favoring proliferation of DEQ-resistant mutants. Furthermore, we demonstrate stress-induced mutagenesis during mouse infections and its inhibition by DEQ. Our work provides a proof-of-concept strategy for drugs to slow evolution in bacteria and generally.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3